Anti-il6 Treatment of Serious COVID-19 Disease With Threatening Respiratory Failure (TOCIVID)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04322773 |
|
Recruitment Status :
Terminated
(The study has been terminated due to changed clinical conditions and too few patients available)
First Posted : March 26, 2020
Last Update Posted : October 9, 2020
|
Sponsor:
Marius Henriksen
Information provided by (Responsible Party):
Marius Henriksen, Frederiksberg University Hospital
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | October 8, 2020 |
| Actual Study Completion Date : | October 8, 2020 |